| Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, E Vilaplana, M Carmona-Iragui, B Benejam, L Videla, I Barroeta, ... The Lancet 395 (10242), 1988-1997, 2020 | 242 | 2020 |
| Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, M Carmona-Iragui, B Benejam, S Fernández, L Videla, ... The Lancet Neurology 17 (10), 860-869, 2018 | 177 | 2018 |
| Association of Alzheimer disease with life expectancy in people with Down syndrome MF Iulita, DG Chavez, MK Christensen, NV Tamayo, O Plana-Ripoll, ... JAMA network open 5 (5), e2212910-e2212910, 2022 | 81 | 2022 |
| Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study J Pegueroles, A Jiménez, E Vilaplana, V Montal, M Carmona-Iragui, ... Oncotarget 9 (78), 34691, 2018 | 79 | 2018 |
| Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders C Delaby, D Alcolea, M Carmona-Iragui, I Illán-Gala, ... Scientific reports 10 (1), 9161, 2020 | 74 | 2020 |
| The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: a data set for biomarker discovery and validation in neurodegenerative disorders D Alcolea, J Clarimón, M Carmona-Iragui, I Illán-Gala, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019 | 73 | 2019 |
| Prevalence of sleep disorders in adults with down syndrome: a comparative study of self-reported, actigraphic, and polysomnographic findings S Giménez, L Videla, S Romero, B Benejam, S Clos, S Fernández, ... Journal of Clinical Sleep Medicine 14 (10), 1725-1733, 2018 | 72 | 2018 |
| Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal‐dominant Alzheimer's disease M Carmona‐Iragui, M Balasa, B Benejam, D Alcolea, S Fernández, ... Alzheimer's & Dementia 13 (11), 1251-1260, 2017 | 67 | 2017 |
| Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease A Jimenez, J Pegueroles, M Carmona-Iragui, E Vilaplana, V Montal, ... Oncotarget 8 (62), 104706, 2017 | 65 | 2017 |
| Association of apolipoprotein E ɛ4 allele with clinical and multimodal biomarker changes of Alzheimer disease in adults with Down syndrome A Bejanin, MF Iulita, E Vilaplana, M Carmona-Iragui, B Benejam, L Videla, ... JAMA neurology 78 (8), 937-947, 2021 | 55 | 2021 |
| Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis M Carmona‐Iragui, L Videla, A Lleó, J Fortea Developmental Neurobiology 79 (7), 716-737, 2019 | 53 | 2019 |
| Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests B Benejam, L Videla, E Vilaplana, I Barroeta, M Carmona‐Iragui, M Altuna, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 51 | 2020 |
| Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia N Zhu, M Santos-Santos, I Illán-Gala, V Montal, T Estellés, I Barroeta, ... Translational neurodegeneration 10 (1), 50, 2021 | 50 | 2021 |
| Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome A Lleó, H Zetterberg, J Pegueroles, TK Karikari, M Carmona-Iragui, ... Nature communications 12 (1), 4304, 2021 | 42 | 2021 |
| Use of plasma biomarkers for AT (N) classification of neurodegenerative dementias D Alcolea, C Delaby, L Muñoz, S Torres, T Estellés, N Zhu, I Barroeta, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (11), 1206-1214, 2021 | 41 | 2021 |
| Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study M Carmona-Iragui, D Alcolea, I Barroeta, L Videla, L Muñoz, KL Van Pelt, ... The Lancet Neurology 20 (8), 605-614, 2021 | 40 | 2021 |
| The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone C Delaby, T Estellés, N Zhu, J Arranz, I Barroeta, M Carmona-Iragui, ... Alzheimer's research & therapy 14 (1), 20, 2022 | 37 | 2022 |
| Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer’s disease-related inhibitory circuit dysfunction in adults with Down syndrome O Belbin, MF Xiao, D Xu, M Carmona-Iragui, J Pegueroles, B Benejam, ... Molecular neurodegeneration 15, 1-10, 2020 | 30 | 2020 |
| Diagnostic and prognostic value of the combination of two measures of verbal memory in mild cognitive impairment due to Alzheimer’s disease I Sala, I Illan-Gala, D Alcolea, MB Sánchez-Saudinós, SA Salgado, ... Journal of Alzheimer's Disease 58 (3), 909-918, 2017 | 27 | 2017 |
| Cortical microstructure in the amyotrophic lateral sclerosis–frontotemporal dementia continuum I Illán-Gala, V Montal, J Pegueroles, E Vilaplana, D Alcolea, O Dols-Icardo, ... Neurology 95 (18), e2565-e2576, 2020 | 26 | 2020 |
